AstraZeneca divests rights for Nexium and Vimovo to Grünenthal

AstraZeneca has agreed to divest the prescription medicine rights for Nexium in Europe, as well as the global rights (excluding the US and Japan)...

Mundipharma acquires biosimilars development company

The Mundipharma global network of independent associated companies has added development capabilities to its biosimilars platform with the purchase of biosimilars development company, Cinfa...

BioIVT acquires CTLS a UK blood donor facility

BioIVT acquires Clinical Trials Laboratory Services (CTLS), a donor centre and laboratory based in London, UK. BioIVT, is a provider of research models and...

Tusk Therapeutics to be acquired by Roche

Tusk Therapeutics Ltd has been acquired by Roche. Tusk was founded in 2014 by Droia Oncology Ventures, Tusk’s majority shareholder. Under the terms of...

PharmaDoctor and Star enter into a strategic partnership

PharmaDoctor (owned by Escripts Marketing Ltd), and Star (part of the Uniphar Group), are pleased to announce a strategic partnership between the two companies...

Novo Nordisk acquires Ziylo to accelerate glucose responsive insulin

Ziylo and Novo Nordisk have announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out company based...

Syneos Health acquires advisory & operational solutions provider Kinapse

Syneos Health, Inc. a biopharmaceutical solutions organisation, has announced the acquisition of Kinapse, a market leading advisory and operational solutions provider to the global...

Almirall acquires US medical dermatology portfolio from Allergan

Almirall, S.A. (ALM) has announced the acquisition of a portfolio of five products from Allergan’s Medical Dermatology unit in the United States for $500...

UDG Healthcare acquire Create NYC and SmartAnalyst

UDG Healthcare plc, an international healthcare services provider, is pleased to announce the acquisition of Create NYC, a New York-based disruptive creative communications agency...

Laekna acquires worldwide rights to two oncology assets

Laekna Inc., a biotechnology company headquartered in Shanghai, announced the signing of an agreement with Novartis Pharma for exclusive global rights to develop and...

Latest articles

ViiV Healthcare continues innovative partnership to transform HIV care

ViiV Healthcare continues innovative partnership to transform HIV care

ViiV Healthcare and Chelsea and Westminster Hospital NHS Foundation Trust are continuing their innovative partnership to transform HIV patient care with the launch of...
Next stage of COVID-19 vaccination programme begins

Next stage of COVID-19 vaccination programme begins

The NHS has begun the next stage of its vaccine roll-out programme to a further two priority groups today - those aged 70 and...
GSK announces NICE recommendation for ovarian cancer treatment

NICE recommendation for GSK’s ovarian cancer treatment

National Institute for Health and Care Excellence (NICE) has recommended GSK’s ZEJULA®▼ (niraparib) on the NHS in England for women with advanced high-grade epithelial...

Popular articles

Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
JCVI updates priority list for COVID-19 vaccine

JCVI updates priority list for COVID-19 vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that the first priorities for any COVID-19 vaccination programme should be the prevention of...
Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Nasal spray to protect against COVID-19 is ready for use in humans

Nasal spray to protect against COVID-19 is ready for use in humans

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
GSK announces NICE recommendation for ovarian cancer treatment

NICE recommendation for GSK’s ovarian cancer treatment

National Institute for Health and Care Excellence (NICE) has recommended GSK’s ZEJULA®▼ (niraparib) on the NHS in England for women with advanced high-grade epithelial...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription